This may be associated with hepcidin upregulation leading to impaired iron release [33], explaining the clinical paradox of ‘adequate iron stores with poor EPO response.’ This composite indicator may be superior to single iron parameters in assessing iron utilization impairment in inflammatory states [34], providing new perspectives for anemia management. The gene discussed is HAMP; the disease is anemia (phenotype).